# Senzime AB

- Location (FDA's records): Uppsala, SE
- FDA decisions: 3 (2019–2026): 3 510(k) clearances
- Product codes: KOI (3)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Idmed: 1 (https://510kreport.com/company/idmed)
- Philips Medizin Systeme Boeblingen GmbH: 1 (https://510kreport.com/company/philips-medizin-systeme-boeblingen)
- GE Healthcare: 1 (https://510kreport.com/company/ge-healthcare)

## Firms that cite its devices most
- Nihon Kohden Corporation: 1 (https://510kreport.com/company/nihon-kohden)

## Its most-cited devices
- K190795: Tetragraph Neuromuscular Transmission Monitor (2019), cited by 2
- K220530: Tetragraph Neuromuscular Transmission Monitor (2022), cited by 1

## Recent decisions
- K261098: TetraGraph Neuromuscular Transmission Monitor (SEN 2015)Accessories:TetraSens (SEN 2012)TetraSens Pediatric (SEN 2013)TetraSensitive (SEN 2016)TetraHub (SEN 2017) (May 22, 2026)
- K220530: Tetragraph Neuromuscular Transmission Monitor (Aug 17, 2022)
- K190795: Tetragraph Neuromuscular Transmission Monitor (Oct 18, 2019)

Source page: https://510kreport.com/company/senzime